Clinical Laboratory Services Market Report 2026

The clinical laboratory services market size has grown strongly in recent years. It will grow from $314.18 billion in 2025 to $338.2 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing prevalence of chronic and infectious diseases, expansion of hospital laboratory networks, rising utilization of diagnostic testing in clinical care, growth in preventive healthcare screening, availability of standardized laboratory protocols.

The clinical laboratory services market size is expected to see strong growth in the next few years. It will grow to $448.71 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing demand for personalized medicine diagnostics, rising adoption of point-of-care testing, expansion of genetic and molecular diagnostics, growing investments in laboratory automation, increasing outsourcing of diagnostic services. Major trends in the forecast period include increasing adoption of automated diagnostic platforms, rising demand for high-throughput testing services, growing integration of digital laboratory information systems, expansion of specialized molecular testing services, enhanced focus on rapid turnaround times.

The growing demand for diagnostic testing is expected to drive the expansion of the clinical laboratory services market in the coming years. Diagnostic testing involves medical tests used to detect, confirm, or rule out the presence of a disease or condition in a patient. The rising demand for diagnostic testing is driven by the increasing prevalence of chronic and infectious diseases, as accurate and timely diagnostics are critical for early detection, effective treatment, and proper disease management. Clinical laboratory services support diagnostic testing by delivering precise and prompt analyses, making them essential for early disease identification and management. They help reduce clinical uncertainty by providing accurate laboratory results, improving patient care, and guiding treatment decisions. For example, in December 2024, according to the National Health Service, a UK-based government agency, the number of diagnostic tests performed reached 2,544,809 in 2024, up from 2,312,030 in 2023. Therefore, the increasing demand for diagnostic testing is driving the growth of the clinical laboratory services market.

Key companies in the clinical laboratory services market are focusing on expanding innovative service models such as mobile phlebotomy and at-home specimen collection to improve patient accessibility, convenience, and reach. Mobile phlebotomy involves trained professionals visiting a patient’s home to collect necessary specimens and transport them to a laboratory for testing, offering flexible scheduling, broader geographic coverage for patients with limited mobility, and faster specimen collection. For instance, in November 2023, Quest Diagnostics Inc., a US-based healthcare company, launched Quest Mobile, a mobile phlebotomy service that allows patients to schedule in-home specimen collection for a wide range of laboratory tests. The service is supported by a nationwide network of trained phlebotomists and provides access to over 800 test types, including routine wellness screenings, prenatal and women’s health testing, and infectious disease diagnostics. Quest Mobile offers direct online appointment scheduling, transparent fee visibility, and coordinated same-day or next-day collection in many locations. This service enhances patient convenience, improves access for homebound or underserved populations, supports continuity of care through easier follow-up testing, and extends laboratory service accessibility beyond traditional walk-in centers.

In April 2024, Eurofins Scientific SE, a Luxembourg-based testing laboratories company, acquired Ascend Clinical LLC for an undisclosed amount. Through this acquisition, Eurofins Scientific SE aims to strengthen its global laboratory network and broaden its service offerings in specialized testing markets. Ascend Clinical LLC is a US-based clinical laboratory services company.

Major companies operating in the clinical laboratory services market are Roche Diagnostics India Private Limited, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, IQVIA Laboratories, Labcorp, Quest Diagnostics Incorporated, Geisinger Health System, Eurofins Scientific, Sonic Healthcare Limited, Grifols S.A., BioMérieux SA, SYNLAB Group, Bio-Rad Laboratories Inc., OPKO Health Inc, NeoGenomics Laboratories, Ambry Genetics Corporation, Genova Diagnostics (GDX), Enzo Biochem Inc, Wildcat DX.

North America was the largest region in the clinical laboratory services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical laboratory services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical laboratory services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the clinical laboratory services market by increasing costs of imported diagnostic analyzers, reagents, test kits, laboratory consumables, and automation equipment. Hospital-based and stand-alone laboratories in North America and Europe are most affected due to reliance on imported diagnostic technologies, while Asia-Pacific faces pricing pressure on reagent and equipment supplies. These tariffs are raising operational costs and affecting test pricing structures. At the same time, they are encouraging local reagent manufacturing, regional equipment assembly, and investments in domestic diagnostic technology capabilities.

The clinical laboratory services market research report is one of a series of new reports that provides clinical laboratory services market statistics, including clinical laboratory services industry global market size, regional shares, competitors with a clinical laboratory services market share, detailed clinical laboratory services market segments, market trends and opportunities, and any further data you may need to thrive in the clinical laboratory services industry. This clinical laboratory services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical laboratory services refer to medical testing performed on clinical specimens, such as blood, urine, and tissue, to diagnose, monitor, and prevent diseases. These services provide accurate and timely laboratory results that assist physicians in making informed treatment decisions. The primary purpose of these services is to support disease detection, health assessment, and therapeutic monitoring.

The primary types of tests in clinical laboratory services include genetic testing, clinical chemistry, medical microbiology testing, hematology testing, immunology testing, cytology testing, drug of abuse testing, and others. Genetic testing involves analyzing an individual’s DNA, RNA, chromosomes, or proteins to identify changes or mutations that may indicate a risk for specific diseases or conditions. These tests are performed in various service settings, including hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories, using technologies such as conventional laboratory methods, automated laboratory systems, and point-of-care testing. Clinical laboratory services find applications in fields including bioanalytical and laboratory chemistry services, toxicology testing, cell and gene therapy-related services, preclinical and clinical trial services, drug discovery and development, and others, serving end users such as hospitals, diagnostic laboratories, clinics, and research institutions.

The clinical laboratory services market includes revenues earned by entities through diagnostic testing, routine blood and urine analysis, pathology examinations, genetic testing, and other laboratory-based evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.